Do Patients With Non-Viable Myocardium From Ischemic Cardiomyopathy Benefit From Revascularization? A Systematic

Farideh Davoudi1, Satoshi Miyashita2, Tae Kyung Yoo3

  • 1Department of Medicine, Mass General Brigham-Salem Hospital, MA, USA.

Summary

Revascularization benefits patients with ischemic cardiomyopathy and non-viable myocardium, reducing all-cause mortality compared to medical therapy alone. This finding challenges the necessity of myocardial viability for treatment selection.